BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Coral - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thecoral.net
X-WR-CALDESC:Eventos para Coral
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260526T080000
DTEND;TZID=Europe/Madrid:20260529T170000
DTSTAMP:20260524T223443
CREATED:20260430T082635Z
LAST-MODIFIED:20260430T083645Z
UID:5894-1779782400-1780074000@thecoral.net
SUMMARY:71º Congreso Nacional SEACV Sitges (Barcelona) ·
DESCRIPTION:Sitges (Barcelona) · 26–29 de mayo de 2026 \nEl 71º Congreso de la Sociedad Española de Angiología y Cirugía Vascular (SEACVE) se celebrará del 26 al 29 de mayo de 2026 en el Hotel Meliá Sitges. Reúne a cirujanos vasculares\, angiólogos y especialistas de toda España\, con un área de exposición industrial donde empresas medtech presentan sus últimas innovaciones en dispositivos vasculares\, stents\, sistemas de catéter y materiales biocompatibles. \nPara startups medtech en fases seed o Series A con productos orientados a cirugía vascular o endovascular\, es una vía directa de validación clínica y de inicio de relaciones con jefes de servicio hospitalarios y responsables de compras. El acceso al decisor clínico y al líder de opinión en un entorno concentrado es difícil de replicar fuera de este tipo de congreso especializado. \nCongreso que revisa los últimos avances tecnológicos y clínicos en el tratamiento de enfermedades vasculares\, con fuerte componente de industria de dispositivos médicos. \n🔗 https://congresos-seacv.com/
URL:https://thecoral.net/event/71o-congreso-nacional-seacv/
CATEGORIES:Eventos
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260526T173000
DTEND;TZID=Europe/Madrid:20260526T200000
DTSTAMP:20260524T223443
CREATED:20260521T134830Z
LAST-MODIFIED:20260521T135343Z
UID:6232-1779816600-1779825600@thecoral.net
SUMMARY:From Lab to Market III: Pitch Day
DESCRIPTION:Be part of the closing event of Genesis: From Lab to Market 2026\, where emerging scientific talent takes its first steps toward actionable ventures. \n​After 12 weeks of intensive venture building\, 4 interdisciplinary teams in HealthTech\, FoodTech\, and Biomaterials take the stage to unveil the seed‑stage concepts they’ve developed through the program. \n​At this in‑person Pitch Day in Madrid\, hosted at Fundación Innovación Bankinter\, you’ll experience: \n​• Investor‑ready pitches from emerging scientific founders evaluated by a jury of four experts in venture capital and scientific entrepreneurship. \n​• A roundtable with researchers‑turned‑entrepreneurs. \n​• A networking session connecting innovators\, industry leaders\, and ecosystem partners from across Spain. \n​Attention: The WC will be out of service. \n​ \n​Provisional Program (subject to modification): \n​• 17:00 – Registration opens \n​• 17:30 – Institutional welcome \n\n\n​Carlos Navarrete (Co-Managing Director\, Nucleate Spain) \n\n\n​Claudia María Diz (Innovation Program Manager\, Fundación Innovación Bankinter) \n\n\n​• 17:45 – Pitch presentations from the participant teams \n​The jury will consist of Carlos Cosculluela (Fundación DRO)\, José Carlos Huerta (Fundación Innovación Bankinter)\, Eva Martín (Kinrel)\, and Cruz Mendiguita (BeAble Capital) \n​Presented by Christina Reyburn (Director of Communications\, Nucleate Spain) \n​• 18:30 – Coffee Networking \n​• 19:15 – Roundtable with 3 scientific founders: \n\n\n​Victor Rodríguez-López (Co-Founder\, SureVision Tech) \n\n\n​Laura Vallés Saiz (Co-Founder & CEO\, ELE Biotech) \n\n\n​TBC \n\n\n​Moderated by Alberto González (Director of Events – Madrid\, Nucleate Spain) \n​• 19:40 – Awards ceremony \n​• 19:50 – Closing remarks \n​ \n​Genesis: From Lab To Market is proudly supported by Corporación Hijos de Rivera S.L.\, the official sponsors of the FoodTech track. \n​Partners: Fundación Innovación Bankinter\, Adbaio\, Farmaskills\, Fundación DRO\, Pons IP Scale Lab \n​ \n​About the Host: \n​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions\, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming\, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information\, and visit https://nucleate.org/privacy-policy/ to read our privacy policy. \n​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!: \n​https://nucleate.org/sponsors/ \n\n\n\n\n\nUbicación\n\n\n\n\nFundación Innovación Bankinter\nP.º de la Castellana\, 29\, Chamberí\, 28046 Madrid\, España
URL:https://thecoral.net/event/from-lab-to-market-iii-pitch-day/
CATEGORIES:Eventos
END:VEVENT
END:VCALENDAR